RBC Bioscience Current Assets

RBC Bioscience (6848.TWO) currently reports a current assets of $130M as of June 2026. That compares with $150M in the prior-year period — down 11.1% year over year. Use the charts on this page to explore RBC Bioscience's current assets history and peer comparisons.

RBC Bioscience's current assets decreased from $150M to $130M — a 11.1% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

RBC Bioscience reported $130M in current assets as of June 2026. That compares with $150M in the prior-year period — down 11.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $130M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for RBC Bioscience, and consider following 6848.TWO for alerts when major investors trade the stock.

RBC Bioscience is classified in the Healthcare sector. On current assets, it currently shows $130M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 6848.TWO with unrelated industries.